168 results on '"Han, Ying"'
Search Results
2. [18F]-D3FSP β-amyloid PET imaging in older adults and alzheimer’s disease
- Author
-
Li, Anqi, Zhao, Ruiyue, Zhang, Mingkai, Sun, Pan, Cai, Yue, Zhu, Lin, Kung, Hank, Han, Ying, Wang, Xinlu, and Guo, Tengfei
- Published
- 2024
- Full Text
- View/download PDF
3. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer’s disease
- Author
-
Guo, Tengfei, Li, Anqi, Sun, Pan, He, Zhengbo, Cai, Yue, Lan, Guoyu, Liu, Lin, Li, Jieyin, Yang, Jie, Zhu, Yalin, Zhao, Ruiyue, Chen, Xuhui, Shi, Dai, Liu, Zhen, Wang, Qingyong, Xu, Linsen, Zhou, Liemin, Ran, Pengcheng, Wang, Xinlu, Sun, Kun, Lu, Jie, and Han, Ying
- Published
- 2024
- Full Text
- View/download PDF
4. Pathophysiology characterization of Alzheimer’s disease in South China’s aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)
- Author
-
Liu, Zhen, Shi, Dai, Cai, Yue, Li, Anqi, Lan, Guoyu, Sun, Pan, Liu, Lin, Zhu, Yalin, Yang, Jie, Zhou, Yajing, Guo, Lizhi, Zhang, Laihong, Deng, Shuqing, Chen, Shuda, Yu, Xianfeng, Chen, Xuhui, Zhao, Ruiyue, Wang, Qingyong, Ran, Pengcheng, Xu, Linsen, Zhou, Liemin, Sun, Kun, Wang, Xinlu, Peng, Qiyu, Han, Ying, and Guo, Tengfei
- Published
- 2024
- Full Text
- View/download PDF
5. Comparison of 18F-FDG PET and arterial spin labeling MRI in evaluating Alzheimer’s disease and amnestic mild cognitive impairment using integrated PET/MR
- Author
-
Bi, Sheng, Yan, Shaozhen, Chen, Zhigeng, Cui, Bixiao, Shan, Yi, Yang, Hongwei, Qi, Zhigang, Zhao, Zhilian, Han, Ying, and Lu, Jie
- Published
- 2024
- Full Text
- View/download PDF
6. Reproducible Abnormalities and Diagnostic Generalizability of White Matter in Alzheimer’s Disease
- Author
-
Qu, Yida, Wang, Pan, Yao, Hongxiang, Wang, Dawei, Song, Chengyuan, Yang, Hongwei, Zhang, Zengqiang, Chen, Pindong, Kang, Xiaopeng, Du, Kai, Fan, Lingzhong, Zhou, Bo, Han, Tong, Yu, Chunshui, Zhang, Xi, Zuo, Nianming, Jiang, Tianzi, Zhou, Yuying, Liu, Bing, Han, Ying, Lu, Jie, and Liu, Yong
- Published
- 2023
- Full Text
- View/download PDF
7. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment
- Author
-
Jiang, Jiehui, Sheng, Can, Chen, Guanqun, Liu, Chunhua, Jin, Shichen, Li, Lanlan, Jiang, Xueyan, and Han, Ying
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Clinical Sciences ,Genetics ,Biomedical Imaging ,Dementia ,Neurodegenerative ,Neurosciences ,Aging ,Prevention ,Clinical Research ,Alzheimer's Disease ,Brain Disorders ,Acquired Cognitive Impairment ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Neurological ,Mental health ,Humans ,Aged ,Alzheimer Disease ,Positron-Emission Tomography ,Cognitive Dysfunction ,Fluorodeoxyglucose F18 ,Brain ,Glucose ,Pattern ,Brain ageing ,Positron emission tomography ,Glucose metabolism ,Alzheimer’s Disease Neuroimaging Initiative ,Clinical sciences - Abstract
Exploring individual hallmarks of brain ageing is important. Here, we propose the age-related glucose metabolism pattern (ARGMP) as a potential index to characterize brain ageing in cognitively normal (CN) elderly people. We collected 18F-fluorodeoxyglucose (18F-FDG) PET brain images from two independent cohorts: the Alzheimer's Disease Neuroimaging Initiative (ADNI, N = 127) and the Xuanwu Hospital of Capital Medical University, Beijing, China (N = 84). During follow-up (mean 80.60 months), 23 participants in the ADNI cohort converted to cognitive impairment. ARGMPs were identified using the scaled subprofile model/principal component analysis method, and cross-validations were conducted in both independent cohorts. A survival analysis was further conducted to calculate the predictive effect of conversion risk by using ARGMPs. The results showed that ARGMPs were characterized by hypometabolism with increasing age primarily in the bilateral medial superior frontal gyrus, anterior cingulate and paracingulate gyri, caudate nucleus, and left supplementary motor area and hypermetabolism in part of the left inferior cerebellum. The expression network scores of ARGMPs were significantly associated with chronological age (R = 0.808, p
- Published
- 2022
8. Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer’s disease
- Author
-
Jiang, Jiehui, Wang, Min, Alberts, Ian, Sun, Xiaoming, Li, Taoran, Rominger, Axel, Zuo, Chuantao, Han, Ying, Shi, Kuangyu, and Initiative, for the Alzheimer’s Disease Neuroimaging
- Published
- 2022
- Full Text
- View/download PDF
9. Subjective cognitive decline-related worries modulate the relationship between global amyloid load and gray matter volume in preclinical Alzheimer’s disease
- Author
-
Wang, Xiaoqi, Wang, Min, Wang, Xiaoni, Zhou, Feifan, Jiang, Jiehui, Liu, Hesheng, and Han, Ying
- Published
- 2022
- Full Text
- View/download PDF
10. Altered Connectedness of the Brain Chronnectome During the Progression to Alzheimer’s Disease
- Author
-
Ghanbari, Maryam, Zhou, Zhen, Hsu, Li-Ming, Han, Ying, Sun, Yu, Yap, Pew-Thian, Zhang, Han, and Shen, Dinggang
- Published
- 2022
- Full Text
- View/download PDF
11. β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer’s disease and predicts cerebral amyloidosis
- Author
-
Li, Tao-Ran, Yao, Yun-Xia, Jiang, Xue-Yan, Dong, Qiu-Yue, Yu, Xian-Feng, Wang, Ting, Cai, Yan-Ning, and Han, Ying
- Published
- 2022
- Full Text
- View/download PDF
12. A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
- Author
-
Li, Lanlan, Yu, Xianfeng, Sheng, Can, Jiang, Xueyan, Zhang, Qi, Han, Ying, and Jiang, Jiehui
- Published
- 2022
- Full Text
- View/download PDF
13. Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer’s disease: a cross-sectional analysis from the SILCODE study
- Author
-
Sheng, Can, Yang, Kun, He, Beiqi, Du, Wenying, Cai, Yanning, and Han, Ying
- Published
- 2022
- Full Text
- View/download PDF
14. Convergent Multimodal Imaging Abnormalities in the Dorsal Precuneus in Subjective Cognitive Decline.
- Author
-
Li, Xuan-Yu, Yuan, Li-Xia, Ding, Chang-Chang, Guo, Teng-Fei, Du, Wen-Ying, Jiang, Jie-Hui, Jessen, Frank, Zang, Yu-Feng, and Han, Ying
- Subjects
POSITRON emission tomography ,FUNCTIONAL magnetic resonance imaging ,DEFAULT mode network ,ALZHEIMER'S disease ,GLUCOSE metabolism - Abstract
Background: A range of imaging modalities have reported Alzheimer's disease-related abnormalities in individuals experiencing subjective cognitive decline (SCD). However, there has been no consistent local abnormality identified across multiple neuroimaging modalities for SCD. Objective: We aimed to investigate the convergent local alterations in amyloid-β (Aβ) deposition, glucose metabolism, and resting-state functional MRI (RS-fMRI) metrics in SCD. Methods: Fifty SCD patients (66.4±5.7 years old, 19 men [38%]) and 15 normal controls (NC) (66.3±4.4 years old, 5 men [33.3%]) were scanned with both [
18 F]-florbetapir PET and [18 F]-fluorodeoxyglucose PET, as well as simultaneous RS-fMRI from February 2018 to November 2018. Voxel-wise metrics were retrospectively analyzed, including Aβ deposition, glucose metabolism, amplitude of low frequency fluctuation (ALFF), regional homogeneity (ReHo), and degree centrality(DC). Results: The SCD group showed increased Aβ deposition and glucose metabolism (p < 0.05, corrected), as well as decreased ALFF, ReHo, and DC (p < 0.05, uncorrected) in the left dorsal precuneus (dPCu). Furthermore, the dPCu illustrated negative resting-state functional connectivity with the default mode network. Regarding global Aβ deposition positivity, the Aβ deposition in the left dPCu showed a gradient change, i.e., Aβ positive SCD > Aβ negative SCD > Aβ negative NC. Additionally, both Aβ positive SCD and Aβ negative SCD showed increased glucose metabolism and decreased RS-fMRI metrics in the dPCu. Conclusions: The dorsal precuneus, an area implicated in early AD, shows convergent neuroimaging alterations in SCD, and might be more related to other cognitive functions (e.g., unfocused attention) than episodic memory. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
15. Leveraging large-scale genetic data to assess the causal impact of COVID-19 on multisystemic diseases.
- Author
-
Zhang, Xiangyang, Jiang, Zhaohui, Ma, Jiayao, Qi, Yaru, Li, Yin, Zhang, Yan, Liu, Yihan, Wei, Chaochao, Chen, Yihong, Liu, Ping, Peng, Yinghui, Tan, Jun, Han, Ying, Zeng, Shan, Cai, Changjing, and Shen, Hong
- Subjects
ALZHEIMER'S disease ,GENOME-wide association studies ,BILIARY liver cirrhosis ,COVID-19 ,CELIAC disease ,DIABETIC nephropathies - Abstract
Background: The long-term impacts of COVID-19 on human health are a major concern, yet comprehensive evaluations of its effects on various health conditions are lacking. Methods: This study aims to evaluate the role of various diseases in relation to COVID-19 by analyzing genetic data from a large-scale population over 2,000,000 individuals. A bidirectional two-sample Mendelian randomization approach was used, with exposures including COVID-19 susceptibility, hospitalization, and severity, and outcomes encompassing 86 different diseases or traits. A reverse Mendelian randomization analysis was performed to assess the impact of these diseases on COVID-19. Results: Our analysis identified causal relationships between COVID-19 susceptibility and several conditions, including breast cancer (OR = 1.0073, 95% CI = 1.0032–1.0114, p = 5 × 10 − 4), ER + breast cancer (OR = 0.5252, 95% CI = 0.3589–0.7685, p = 9 × 10 − 4), and heart failure (OR = 1.0026, 95% CI = 1.001–1.0042, p = 0.002). COVID-19 hospitalization was causally linked to heart failure (OR = 1.0017, 95% CI = 1.0006–1.0028, p = 0.002) and Alzheimer's disease (OR = 1.5092, 95% CI = 1.1942–1.9072, p = 0.0006). COVID-19 severity had causal effects on primary biliary cirrhosis (OR = 2.6333, 95% CI = 1.8274–3.7948, p = 2.059 × 10 − 7), celiac disease (OR = 0.0708, 95% CI = 0.0538–0.0932, p = 9.438 × 10–80), and Alzheimer's disease (OR = 1.5092, 95% CI = 1.1942–1.9072, p = 0.0006). Reverse MR analysis indicated that rheumatoid arthritis, diabetic nephropathy, multiple sclerosis, and total testosterone (female) influence COVID-19 outcomes. We assessed heterogeneity and horizontal pleiotropy to ensure result reliability and employed the Steiger directionality test to confirm the direction of causality. Conclusions: This study provides a comprehensive analysis of the causal relationships between COVID-19 and diverse health conditions. Our findings highlight the long-term impacts of COVID-19 on human health, emphasizing the need for continuous monitoring and targeted interventions for affected individuals. Future research should explore these relationships to develop comprehensive healthcare strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. The link between gut microbiome and Alzheimer's disease: From the perspective of new revised criteria for diagnosis and staging of Alzheimer's disease.
- Author
-
Liang, Yuan, Liu, Congcong, Cheng, Manman, Geng, Lijie, Li, Jing, Du, Wenying, Song, Minfang, Chen, Nian, Yeleen, Traore Aicha Noura, Song, Li, Wang, Xiaoni, Han, Ying, and Sheng, Can
- Abstract
Over the past decades, accumulating evidence suggests that the gut microbiome exerts a key role in Alzheimer's disease (AD). The Alzheimer's Association Workgroup is updating the diagnostic criteria for AD, which changed the profiles and categorization of biomarkers from "AT(N)" to "ATNIVS." Previously, most of studies focus on the correlation between the gut microbiome and amyloid beta deposition ("A"), the initial AD pathological feature triggering the "downstream" tauopathy and neurodegeneration. However, limited research investigated the interactions between the gut microbiome and other AD pathogenesis ("TNIVS"). In this review, we summarize current findings of the gut microbial characteristics in the whole spectrum of AD. Then, we describe the association of the gut microbiome with updated biomarker categories of AD pathogenesis. In addition, we outline the gut microbiome‐related therapeutic strategies for AD. Finally, we discuss current key issues of the gut microbiome research in the AD field and future research directions. Highlights: The new revised criteria for Alzheimer's disease (AD) proposed by the Alzheimer's Association Workgroup have updated the profiles and categorization of biomarkers from "AT(N)" to "ATNIVS."The associations of the gut microbiome with updated biomarker categories of AD pathogenesis are described.Current findings of the gut microbial characteristics in the whole spectrum of AD are summarized.Therapeutic strategies for AD based on the gut microbiome are proposed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. An effective and robust lattice Boltzmann model guided by atlas for hippocampal subregions segmentation.
- Author
-
Liu, Yingqian, Wang, Min, Yu, Xianfeng, Han, Ying, Jiang, Jiehui, and Yan, Zhuangzhi
- Subjects
FUNCTIONAL magnetic resonance imaging ,TRAFFIC congestion ,ALZHEIMER'S disease ,MONTREAL Cognitive Assessment ,ATLASES ,MILD cognitive impairment ,MINI-Mental State Examination - Abstract
Background: Given the varying vulnerability of the rostral and caudal regions of the hippocampus to neuropathology in the Alzheimer's disease (AD) continuum, accurately assessing structural changes in these subregions is crucial for early AD detection. The development of reliable and robust automatic segmentation methods for hippocampal subregions (HS) is of utmost importance. Objective: Our aim is to propose and validate a HS segmentation model that is both training‐free and highly generalizable. This method should exhibit comparable accuracy and efficiency to state‐of‐the‐art techniques. The segmented HS can serve as a biomarker for studying the progression of AD. Methods: We utilized the functional magnetic resonance imaging of the Brain's Integrated Registration and Segmentation Tool (FIRST) to segment the entire hippocampus. By intersecting the segmentation results with the Brainnetome (BN) atlas, we obtained coarse segmentation of the four HS regions. This coarse segmentation was then employed as a shape prior term in the lattice Boltzmann (LB) model, as well as for initializing contours. Additionally, image gradients and local gray levels were integrated into the external force terms of the LB model to refine the coarse segmentation results. We assessed the segmentation accuracy of the model using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset and evaluated the potential of the segmentation results as AD biomarkers on both the ADNI and Xuanwu datasets. Results: The median Dice similarity coefficients (DSC) for the left caudal, right caudal, left rostral, and right rostral hippocampus were 0.87, 0.88, 0.88, and 0.89, respectively. The proportion of segmentation results with a DSC exceeding 0.8 was 77%, 78%, 77%, and 94% for the respective regions. In terms of volume, the correlation coefficients between the segmentation results of the four HS regions and the gold standard were 0.95, 0.93, 0.96, and 0.96, respectively. Regarding asymmetry, the correlation coefficient between the segmentation result's right caudal minus left caudal and the corresponding gold standard was 0.91, while for right rostral minus left rostral, it was 0.93. Over time, we observed a decline in the volumes of the four HS regions and the total hippocampal volume of mild cognitive impairment (MCI) converters. Analysis of inter‐group differences revealed that, except for the right rostral region in the ADNI dataset, the p‐values for the four HS regions in the normal controls (NC), MCI, and AD groups from both datasets were all below 0.05. The right caudal hippocampal volume demonstrated correlation coefficients of 0.47 and 0.43 with the mini‐mental state examination (MMSE) and Montreal cognitive assessment (MoCA), respectively. Similarly, the left rostral hippocampal volume showed correlation coefficients of 0.50 and 0.58 with MMSE and MoCA, respectively. Conclusions: Our framework allows for direct application to different brain magnetic resonance (MR) datasets without the need for training. It eliminates the requirement for complex image preprocessing steps while achieving segmentation accuracy comparable to deep learning (DL) methods even with small sample sizes. Compared to traditional active contour models (ACM) and atlas‐based methods, our approach exhibits significant speed advantages. The segmented HS regions hold promise as potential biomarkers for studying the progression of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using 18F‐FDG PET/MRI Radiomics.
- Author
-
Chen, Zhigeng, Bi, Sheng, Shan, Yi, Cui, Bixiao, Yang, Hongwei, Qi, Zhigang, Zhao, Zhilian, Han, Ying, Yan, Shaozhen, and Lu, Jie
- Subjects
ALZHEIMER'S disease ,RADIOMICS ,AMNESTIC mild cognitive impairment ,EARLY diagnosis ,RECEIVER operating characteristic curves - Abstract
Purpose: This study aimed to explore the utility of hippocampal radiomics using multiparametric simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) for early diagnosis of Alzheimer's disease (AD). Methods: A total of 53 healthy control (HC) participants, 55 patients with amnestic mild cognitive impairment (aMCI), and 51 patients with AD were included in this study. All participants accepted simultaneous PET/MRI scans, including 18F‐fluorodeoxyglucose (18F‐FDG) PET, 3D arterial spin labeling (ASL), and high‐resolution T1‐weighted imaging (3D T1WI). Radiomics features were extracted from the hippocampus region on those three modal images. Logistic regression models were trained to classify AD and HC, AD and aMCI, aMCI and HC respectively. The diagnostic performance and radiomics score (Rad‐Score) of logistic regression models were evaluated from 5‐fold cross‐validation. Results: The hippocampal radiomics features demonstrated favorable diagnostic performance, with the multimodal classifier outperforming the single‐modal classifier in the binary classification of HC, aMCI, and AD. Using the multimodal classifier, we achieved an area under the receiver operating characteristic curve (AUC) of 0.98 and accuracy of 96.7% for classifying AD from HC, and an AUC of 0.86 and accuracy of 80.6% for classifying aMCI from HC. The value of Rad‐Score differed significantly between the AD and HC (p < 0.001), aMCI and HC (p < 0.001) groups. Decision curve analysis showed superior clinical benefits of multimodal classifiers compared to neuropsychological tests. Conclusion: Multiparametric hippocampal radiomics using PET/MRI aids in the identification of early AD, and may provide a potential biomarker for clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Frequency-dependent changes in fractional amplitude of low-frequency oscillations in Alzheimer’s disease: a resting-state fMRI study
- Author
-
Yang, Liu, Yan, Yan, Li, Yuxia, Hu, Xiaochen, Lu, Jie, Chan, Piu, Yan, Tianyi, and Han, Ying
- Published
- 2020
- Full Text
- View/download PDF
20. Dynamic network connectivity predicts subjective cognitive decline: the Sino-Longitudinal Cognitive impairment and dementia study
- Author
-
Dong, Guozhao, Yang, Liu, Li, Chiang-shan R., Wang, Xiaoni, Zhang, Yihe, Du, Wenying, Han, Ying, and Tang, Xiaoying
- Published
- 2020
- Full Text
- View/download PDF
21. Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population
- Author
-
Dong, Qiu-Yue, Li, Tao-Ran, Jiang, Xue-Yan, Wang, Xiao-Ni, Han, Ying, and Jiang, Jie-Hui
- Published
- 2021
- Full Text
- View/download PDF
22. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer’s disease
- Author
-
Yan, Shaozhen, Zheng, Chaojie, Cui, Bixiao, Qi, Zhigang, Zhao, Zhilian, An, Yanhong, Qiao, Liyan, Han, Ying, Zhou, Yun, and Lu, Jie
- Published
- 2020
- Full Text
- View/download PDF
23. Impaired Parahippocampal Gyrus–Orbitofrontal Cortex Circuit Associated with Visuospatial Memory Deficit as a Potential Biomarker and Interventional Approach for Alzheimer Disease
- Author
-
Zhu, Lin, Wang, Zan, Du, Zhanhong, Qi, Xinyang, Shu, Hao, Liu, Duan, Su, Fan, Ye, Qing, Liu, Xuemei, Zhou, Zheng, Tang, Yongqiang, Song, Ru, Wang, Xiaobin, Lin, Li, Li, Shijiang, Han, Ying, Wang, Liping, and Zhang, Zhijun
- Published
- 2020
- Full Text
- View/download PDF
24. Acupuncture Modulates Resting State Hippocampal Functional Connectivity in Alzheimer Disease
- Author
-
Wang, Zhiqun, Liang, Peipeng, Zhao, Zhilian, Han, Ying, Song, Haiqing, Xu, Jianyang, Lu, Jie, and Li, Kuncheng
- Subjects
Clinical Research ,Mind and Body ,Neurodegenerative ,Neurosciences ,Brain Disorders ,Aging ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Dementia ,Alzheimer's Disease ,Complementary and Integrative Health ,Acquired Cognitive Impairment ,2.1 Biological and endogenous factors ,Aetiology ,Neurological ,Acupuncture Points ,Acupuncture Therapy ,Aged ,Alzheimer Disease ,Brain Mapping ,Case-Control Studies ,Female ,Hippocampus ,Humans ,Male ,Nerve Net ,Neuropsychological Tests ,Rest ,General Science & Technology - Abstract
Our objective is to clarify the effects of acupuncture on hippocampal connectivity in patients with Alzheimer disease (AD) using functional magnetic resonance imaging (fMRI). Twenty-eight right-handed subjects (14 AD patients and 14 healthy elders) participated in this study. Clinical and neuropsychological examinations were performed on all subjects. MRI was performed using a SIEMENS verio 3-Tesla scanner. The fMRI study used a single block experimental design. We first acquired baseline resting state data during the initial 3 minutes and then performed acupuncture stimulation on the Tai chong and He gu acupoints for 3 minutes. Last, we acquired fMRI data for another 10 minutes after the needle was withdrawn. The preprocessing and data analysis were performed using statistical parametric mapping (SPM5) software. Two-sample t-tests were performed using data from the two groups in different states. We found that during the resting state, several frontal and temporal regions showed decreased hippocampal connectivity in AD patients relative to control subjects. During the resting state following acupuncture, AD patients showed increased connectivity in most of these hippocampus related regions compared to the first resting state. In conclusion, we investigated the effect of acupuncture on AD patients by combing fMRI and traditional acupuncture. Our fMRI study confirmed that acupuncture at Tai chong and He gu can enhance the hippocampal connectivity in AD patients.
- Published
- 2014
25. APOEε4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial.
- Author
-
Zeng, Yanfang, Du, Wenying, Zhang, Mingkai, Walker, Ariel, Han, Ying, and Ding, Yuchuan
- Subjects
COGNITIVE testing ,ALZHEIMER'S disease ,AGE groups ,APOLIPOPROTEIN E ,CROSS-sectional method - Abstract
Objective: To explore the association between the apolipoprotein E (APOE) genotype and objectively assessed cognitive function. Methods: In this cross-sectional study, 537 participants underwent a neuropsychological assessment for cognitive function and blood testing for APOE genotype. Based on cognitive test results, participants were stratified into two cohorts: Cognitively Unimpaired participants (CU) and Cognitively Impaired participants (CI). The CI group was further divided into Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD). Furthermore, we conducted age stratification, categorizing participants into three age groups: age 1: <65 years, age 2: 65–75 years, and age 3: >75 years. We assessed the disparities in cognitive function associated with ε4 carrier status across different age brackets. Plasma amyloid-β levels were measured in a cohort of 294 participants to investigate potential interactions involving ε4 carrier status, diagnosis, sex, or plasma markers. Results: The APOE genotypic distribution among the 537 participants was characterized as follows: ε2/ε2 (5 participants), ε2/ε3 (67), ε2/ε4 (13), ε3/ε3 (330), ε3/ε4 (113), and ε4/ε4 (9). Allele frequencies were: ε3 at 78.21%, ε4 at 13.41%, and ε2 at 8.38%. Notably, the ε4 carrier frequency was markedly elevated in the AD group at 81.8% when compared to MCI at 32.8% and CU at 21.3% (p < 0.05). Within the Cognitively Unimpaired (CU) cohort, the sole discernible contrast between ε4+ and ε4− emerged in STT-B (p < 0.05). Within the CI group, ε4 carriers showed statistically poorer scores as compared to non-ε4 carriers in several cognitive tests (p < 0.05). Age stratification result revealed that, among ε4 carriers, cognitive function scores within the age 3 group were significantly inferior to those of age 1 and age 2 groups (p < 0.05). Plasma amyloid-β detection was applied to the 294 participants. We tested plasma amyloid-β (Aβ42) and plasma amyloid-β (Aβ40) levels and calculated the Aβ42/Aβ40 ratio. We found that among female ε4 carriers, both Aβ42 and the Aβ42/Aβ40 ratio were notably lower than their male counterparts (p < 0.05). Conclusions: The ε3/ε3 was the most prevalent among participants, succeeded by ε3/ε4 and ε2/ε3. The least prevalent were ε2/ε4, ε4/ε4, and ε2/ε2 genotypes. The ε3 was predominant, followed by the ε4 and ε2. Individuals with the ε4 allele exhibited significant cognitive impairment, with an especially high prevalence in AD group at 81.8%. The study unveils a pronounced correlation between the ε4 allele and cognitive deficits, implying its potential role in the advancement and severity of cognitive disorders, notably Alzheimer's disease. Cognitive function declines with age in individuals carrying the ε4, and women are more affected by ε4. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Research progress of large-scale brain network of Alzheimer's disease based on MRI analysis.
- Author
-
HAN Ying-mei, LI Yijie, ZHANG Heng, LV Jing, ZHANG Yi, QIAO Yingbo, LIN Nan, XU Huiyong, and WANG Feng
- Abstract
With the advent of an aging society, Alzheimer's disease (AD) has gradually become a major ailment affecting the elderly. AD is a neurodegenerative disorder associated with cognitive impairments. In AD patients, brain network connections are disrupted, and their topological properties are also affected, leading to the disintegration of anatomical and functional connections. Anatomical connections can be tracked and evaluated using structural magnetic imaging (MRI) and diffusion tensor imaging ( DTI), while functional connections are detected through functional MRI to assess their connectivity status. This review incorporates the findings of previous scholars and summarizes the current research of AD. It mainly discusses the imaging characteristics of large-scale brain network changes in AD patients, so as to provide researchers with scientific and objective imaging markers for AD prediction and early diagnosis, as well as future research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
27. Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of 18F-FDG-PET.
- Author
-
Zhang, Qi, Fan, Chunqiu, Wang, Luyao, Li, Taoran, Wang, Min, Han, Ying, Jiang, Jiehui, and for the Alzheimer's Disease Neuroimaging Initiative, Weiner, Michael W., Aisen, Paul, Petersen, Ronald, Jack, Clifford R., Jagust, William, Trojanowski, John Q., Toga, Arthur W., Beckett, Laurel, Green, Robert C., Saykin, Andrew J., Morris, John, and Shaw, Leslie M.
- Subjects
ALZHEIMER'S disease ,CINGULATE cortex ,GLUCOSE metabolism ,POSITRON emission tomography ,PEARSON correlation (Statistics) ,PREDICTIVE validity - Abstract
Amyloid-β (Aβ) and tau are important biomarkers to predict the progression of cognitively unimpaired (CU) to dementia due to Alzheimer's disease (AD), according to the diagnosis framework from the US National Institute on Aging and the Alzheimer's Association (NIA-AA). However, it is clinically difficult to predict those subjects who were already with Aβ positive (A +) or tau positive (T +). As a typical characteristic of neurodegeneration in the diagnosis framework, the hypometabolism of the posterior cingulate cortex (PCC) has significant clinical value in the early prediction and prevention of AD. In this paper, we proposed the glucose metabolism in the PCC as a biomarker supplement to Aβ and tau biomarkers. First, we calculated the standard uptake value ratio (SUVR) of PCC based on fluorodeoxyglucose positron emission computed tomography (FDG PET) imaging. Secondly, we performed Kaplan–Meier (KM) survival analyses to explore the predictive performance of PCC SUVR, and the hazard ratio (HR) was calculated. Finally, we performed Pearson correlation analyses to explore the physiological significance of PCC SUVR. As a result, the PCC SUVR showed a consistent downward trend along the AD continuum. KM analyses showed better predictive performance when we combined PCC SUVR with cerebro-spinal fluid (CSF) Aβ
42 (from HR = 2.56 to 3.00 within 5 years; from HR = 2.76 to 4.20 within 10 years) and ptau-181 (from 2.83 to 3.91 within 5 years; from HR = 2.32 to 4.17 within 10 years). There was a slight correlation between Aβ42 /Aβ40 and PCC SUVR (r = 0.14, p = 0.02). In addition, several cognition scales were also correlated to PCC SUVR (from r = –0.407 to 0.383, p < 0.05). Our results showed that glucose metabolism in PCC may be a potential biomarker supplement to the Aβ and tau biomarkers to predict the progression of CU to AD. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
28. Sleep and APOE‐ε4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline in older adults.
- Author
-
Yu, Xianfeng, Zhou, Xia, He, Zhengbo, He, Beiqi, Wan, Ke, Wei, Min, Guo, Tengfei, and Han, Ying
- Subjects
COGNITION disorders ,OLDER people ,SLEEP ,SLEEP disorders ,ALZHEIMER'S patients ,BIOMARKERS - Abstract
Background: Sleep disorders are prevalent among patients with Alzheimer's disease (AD), and the APOE ε4 genotype is a key genetic risk factor for sporadic AD. However, the combined effect of the genotype and sleep disorders on cognitive decline remains uncertain. Methods: A total of 972 participants were drawn from the SILCODE cohort, comprising 655 without the ε4 allele (APOE−) and 317 with ε4 allele (APOE+). Data were collected, including neuropsychological assessments, sleep measurements, plasma biomarkers, and PET imaging. A Sleep Composite Index (SCI) was created, categorizing participants into high risk (Sleep+) and low risk (Sleep−). Results: Significant predictions of dementia risk associated with plasma p‐tau181, neurofilament light chain (NfL), and SCI. Individuals with both Sleep+ and APOE+ had a higher risk of dementia compared to those with Sleep‐. The Sleep+/APOE+ group had higher plasma NfL levels than the Sleep−/APOE− group. Similar trends emerged in plasma NfL levels among the Aβ PET‐positive subgroup. Plasma NfL levels explained 23% of the relationship between SCI and cognitive impairment. Conclusion: Our study highlights sleep disorder was associated with cognitive decline, with plasma NfL playing a partial mediating role. These findings explain how sleep disorders affect cognitive function and emphasize the importance of healthy sleep for older adults. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Comparison of 18F-FDG PET and arterial spin labeling MRI in evaluating Alzheimer's disease and amnestic mild cognitive impairment using integrated PET/MR.
- Author
-
Bi, Sheng, Yan, Shaozhen, Chen, Zhigeng, Cui, Bixiao, Shan, Yi, Yang, Hongwei, Qi, Zhigang, Zhao, Zhilian, Han, Ying, and Lu, Jie
- Subjects
AMNESTIC mild cognitive impairment ,ALZHEIMER'S disease ,SPIN labels ,HYPERPERFUSION ,CEREBRAL circulation ,ALZHEIMER'S patients ,TEMPORAL lobe - Abstract
Background: Developing biomarkers for early stage AD patients is crucial. Glucose metabolism measured by
18 F-FDG PET is the most common biomarker for evaluating cellular energy metabolism to diagnose AD. Arterial spin labeling (ASL) MRI can potentially provide comparable diagnostic information to18 F-FDG PET in patients with neurodegenerative disorders. However, the conclusions about the diagnostic performance of AD are still controversial between18 F-FDG PET and ASL. This study aims to compare quantitative cerebral blood flow (CBF) and glucose metabolism measured by18 F-FDG PET diagnostic values in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI) using integrated PET/MR. Results: Analyses revealed overlapping between decreased regional rCBF and18 F-FDG PET SUVR in patients with AD compared with NC participants in the bilateral parietotemporal regions, frontal cortex, and cingulate cortex. Compared with NC participants, patients with aMCI exclusively demonstrated lower18 F-FDG PET SUVR in the bilateral temporal cortex, insula cortex, and inferior frontal cortex. Comparison of the rCBF in patients with aMCI and NC participants revealed no significant difference (P > 0.05). The ROC analysis of rCBF in the meta-ROI could diagnose patients with AD (AUC, 0.87) but not aMCI (AUC, 0.61). The specificity of diagnosing aMCI has been improved to 75.56% when combining rCBF and18 F-FDG PET SUVR. Conclusion: ASL could detect similar aberrant patterns of abnormalities compared to18 F-FDG PET in patients with AD compared with NC participants but not in aMCI. The diagnostic efficiency of18 F-FDG-PET for AD and aMCI patients remained higher to ASL. Our findings support that applying18 F-FDG PET may be preferable for diagnosing AD and aMCI. Key points: Hypometabolic brain areas are more widespread in patients with AD and aMCI than hypoperfused brain areas.18 F-FDG PET provides superior diagnostic performance over ASL for patients with AD and aMCI. After comprehensive consideration, PET alone is recommended for the diagnosis of AD and aMCI patients. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
30. Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuum.
- Author
-
Zhang, Mingkai, Chen, Haojie, Huang, Weijie, Guo, Tengfei, Ma, Guolin, Han, Ying, and Shu, Ni
- Subjects
ALZHEIMER'S disease ,WHITE matter (Nerve tissue) ,GLIAL fibrillary acidic protein ,LARGE-scale brain networks ,TEMPORAL lobe - Abstract
Both plasma biomarkers and brain network topology have shown great potential in the early diagnosis of Alzheimer's disease (AD). However, the specific associations between plasma AD biomarkers, structural network topology, and cognition across the AD continuum have yet to be fully elucidated. This retrospective study evaluated participants from the Sino Longitudinal Study of Cognitive Decline cohort between September 2009 and October 2022 with available blood samples or 3.0‐T MRI brain scans. Plasma biomarker levels were measured using the Single Molecule Array platform, including β‐amyloid (Aβ), phosphorylated tau181 (p‐tau181), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL). The topological structure of brain white matter was assessed using network efficiency. Trend analyses were carried out to evaluate the alterations of the plasma markers and network efficiency with AD progression. Correlation and mediation analyses were conducted to further explore the relationships among plasma markers, network efficiency, and cognitive performance across the AD continuum. Among the plasma markers, GFAP emerged as the most sensitive marker (linear trend: t = 11.164, p = 3.59 × 10−24; quadratic trend: t = 7.708, p = 2.25 × 10−13; adjusted R2 = 0.475), followed by NfL (linear trend: t = 6.542, p = 2.9 × 10−10; quadratic trend: t = 3.896, p = 1.22 × 10−4; adjusted R2 = 0.330), p‐tau181 (linear trend: t = 8.452, p = 1.61 × 10−15; quadratic trend: t = 6.316, p = 1.05 × 10−9; adjusted R2 = 0.346) and Aβ42/Aβ40 (linear trend: t = −3.257, p = 1.27 × 10−3; quadratic trend: t = −1.662, p = 9.76 × 10−2; adjusted R2 = 0.101). Local efficiency decreased in brain regions across the frontal and temporal cortex and striatum. The principal component of local efficiency within these regions was correlated with GFAP (Pearson's R = −0.61, p = 6.3 × 10−7), NfL (R = −0.57, p = 6.4 × 10−6), and p‐tau181 (R = −0.48, p = 2.0 × 10−4). Moreover, network efficiency mediated the relationship between general cognition and GFAP (ab = −0.224, 95% confidence interval [CI] = [−0.417 to −0.029], p =.0196 for MMSE; ab = −0.198, 95% CI = [−0.42 to −0.003], p =.0438 for MOCA) or NfL (ab = −0.224, 95% CI = [−0.417 to −0.029], p =.0196 for MMSE; ab = −0.198, 95% CI = [−0.42 to −0.003], p =.0438 for MOCA). Our findings suggest that network efficiency mediates the association between plasma biomarkers, specifically GFAP and NfL, and cognitive performance in the context of AD progression, thus highlighting the potential utility of network‐plasma approaches for early detection, monitoring, and intervention strategies in the management of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
- Author
-
Wang, Xiaoqi, Huang, Weijie, Su, Li, Xing, Yue, Jessen, Frank, Sun, Yu, Shu, Ni, and Han, Ying
- Published
- 2020
- Full Text
- View/download PDF
32. Heterogeneity in subjective cognitive decline in the Sino Longitudinal Study on Cognitive Decline(SILCODE): Empirically derived subtypes, structural and functional verification.
- Author
-
Fu, Zhenrong, Zhao, Mingyan, Li, Yuxia, He, Yirong, Wang, Xuetong, Zhou, Zongkui, Han, Ying, and Li, Shuyu
- Subjects
COGNITION disorders ,NEUROPSYCHOLOGICAL tests ,LONGITUDINAL method ,HETEROGENEITY ,GRAY matter (Nerve tissue) - Abstract
Aims: We evaluated whether Subjective Cognitive Decline (SCD) subtypes could be empirically derived within the Sino Longitudinal Study on Cognitive Decline (SILCODE) SCD cohort and examined associated neuroimaging markers, biomarkers, and clinical outcomes. Methods: A cluster analysis was performed on eight neuropsychological test scores from 124 SCD SILCODE participants and 57 normal control (NC) subjects. Structural and functional neuroimaging indices were used to evaluate the SCD subgroups. Results: Four subtypes emerged: (1) dysexecutive/mixed SCD (n = 23), (2) neuropsychiatric SCD (n = 24), (3) amnestic SCD (n = 22), and (4) cluster‐derived normal (n = 55) who exhibited normal performance in neuropsychological tests. Compared with the NC group, each subgroup showed distinct patterns in gray matter (GM) volume and the amplitude of low‐frequency fluctuations (ALFF). Lower fractional anisotropy (FA) values were only found in the neuropsychiatric SCD group relative to NC. Conclusion: The identification of empirically derived SCD subtypes demonstrates the presence of heterogeneity in SCD neuropsychological profiles. The cluster‐derived normal group may represent the majority of SCD individuals who do not show progressive cognitive decline; the dysexecutive/mixed SCD and amnestic SCD might represent high‐risk groups with progressing cognitive decline; and finally, the neuropsychiatric SCD may represent a new topic in SCD research. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. A metabolism‐functional connectome sparse coupling method to reveal imaging markers for Alzheimer's disease based on simultaneous PET/MRI scans.
- Author
-
Wang, Luyao, Xu, Huanyu, Wang, Min, Brendel, Matthias, Rominger, Axel, Shi, Kuangyu, Han, Ying, and Jiang, Jiehui
- Subjects
ALZHEIMER'S disease ,PEARSON correlation (Statistics) ,MAGNETIC resonance imaging ,LARGE-scale brain networks ,GLUCOSE metabolism - Abstract
Abnormal glucose metabolism and hemodynamic changes in the brain are closely related to cognitive function, providing complementary information from distinct biochemical and physiological processes. However, it remains unclear how to effectively integrate these two modalities across distinct brain regions. In this study, we developed a connectome‐based sparse coupling method for hybrid PET/MRI imaging, which could effectively extract imaging markers of Alzheimer's disease (AD) in the early stage. The FDG‐PET and resting‐state fMRI data of 56 healthy controls (HC), 54 subjective cognitive decline (SCD), and 27 cognitive impairment (CI) participants due to AD were obtained from SILCODE project (NCT03370744). For each participant, the metabolic connectome (MC) was constructed by Kullback–Leibler divergence similarity estimation, and the functional connectome (FC) was constructed by Pearson correlation. Subsequently, we measured the coupling strength between MC and FC at various sparse levels, assessed its stability, and explored the abnormal coupling strength along the AD continuum. Results showed that the sparse MC–FC coupling index was stable in each brain network and consistent across subjects. It was more normally distributed than other traditional indexes and captured more SCD‐related brain areas, especially in the limbic and default mode networks. Compared to other traditional indices, this index demonstrated best classification performance. The AUC values reached 0.748 (SCD/HC) and 0.992 (CI/HC). Notably, we found a significant correlation between abnormal coupling strength and neuropsychological scales (p <.05). This study provides a clinically relevant tool for hybrid PET/MRI imaging, allowing for exploring imaging markers in early stage of AD and better understanding the pathophysiology along the AD continuum. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers
- Author
-
Sun, Yu, Wang, Xiaoni, Wang, Yinshan, Dong, Haoming, Lu, Jie, Scheininger, Tohar, Ewers, Michael, Jessen, Frank, Zuo, Xi-Nian, and Han, Ying
- Published
- 2019
- Full Text
- View/download PDF
35. Associations Between Levels of Peripheral NCAPH2 Promoter Methylation and Different Stages of Alzheimer's Disease: A Cross-Sectional Study.
- Author
-
Hao, Shu-Wen, Li, Tao-Ran, Han, Chao, Han, Ying, and Cai, Yan-Ning
- Subjects
ALZHEIMER'S disease ,AMNESTIC mild cognitive impairment ,METHYLATION ,POSITRON emission tomography ,RECEIVER operating characteristic curves - Abstract
Background: Several studies have examined NCAPH2 methylation in amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD), but little is known of NCAPH2 methylation in subjective cognitive decline (SCD). Objective: To examine whether methylation of peripheral NCAPH2 are differentially changed at various phases of AD, and whether it could serve as a diagnostic biomarker for SCD. Methods: A total of 40 AD patients, 52 aMCI patients, 148 SCD patients, and 193 cognitively normal controls (NCs) were recruited in the current case-control study. Besides, 54 cognitively normal individuals have received amyloid positron emission tomography (amyloid PET) scans. Using bisulfite pyrosequencing method, we measured blood DNA methylation in the NCAPH2 gene promoter. Results: The main outcomes were: 1) For SCD, there was no significant difference between SCD and NC regarding NCAPH2 methylation; 2) For aMCI, NCAPH2 methylation at CpG2 were significantly lower in aMCI compared with NC and SCD in the entire population and male subgroup; 3) For AD, NCAPH2 methylation at CpG1 were significantly lower in AD compared with NC among females; 4) A relationship with apolipoprotein E (APOE) ɛ4 status was shown. Receiver operating characteristic (ROC) analysis by combining NCAPH2 methylation, age, education, and APOEɛ4 status could distinguish between patients with aMCI (area under the curve (AUC): 0.742) and AD (AUC: 0.873) from NCs. Conclusion: NCAPH2 methylation levels were altered at the aMCI and AD stage and may be convenient and cost-effective biomarkers of AD and aMCI. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. Individual Proportion Loss of Functional Connectivity Strength: A Novel Individual Functional Connectivity Biomarker for Subjective Cognitive Decline Populations.
- Author
-
Li, Zhuoyuan, Lin, Hua, Zhang, Qi, Shi, Rong, Xu, Huanyu, Yang, Fan, Jiang, Xueyan, Wang, Luyao, Han, Ying, and Jiang, Jiehui
- Subjects
FUNCTIONAL connectivity ,FUNCTIONAL magnetic resonance imaging ,COGNITION disorders ,PEARSON correlation (Statistics) ,RECEIVER operating characteristic curves ,BIOMARKERS - Abstract
Simple Summary: Objective biomarkers for the diagnosis of subjective cognitive decline (SCD) are critical for intervention in the Alzheimer's disease (AD) disease process. Previous research has shown that functional magnetic resonance imaging (fMRI) is a significant tool for detecting abnormal interregional functional connectivity (FC) in SCD populations. However, traditional FC calculations do not reveal the high individual variation in the SCD population. We proposed a new framework for individual proportion loss of functional connectivity strength (IPLFCS) based on FC to identify SCD biomarkers, and further explore the relationship between biomarkers and amyloid deposition as well as neuropsychological performance. The study findings indicated that IPLFCS in the left middle temporal gyrus (LMTG) was identified as a potential biomarker that correlated with cortical amyloid deposition and cognitive performance. High individual variation in the subjective cognitive decline (SCD) population makes functional connectivity (FC) biomarkers unstable. This study proposed a novel individual FC index, named individual proportion loss of functional connectivity strength (IPLFCS), and explored potential biomarkers for SCD using this new index. We proposed an IPLFCS analysis framework and compared it with traditional FC in Chinese and Western cohorts. Post hoc tests were used to determine biomarkers. Pearson's correlation analysis was used to investigate the correlation between neuropsychological scores or cortical amyloid deposits and IPLFCS biomarkers. Receiver operating characteristic curves were utilized to evaluate the ability of potential biomarkers to distinguish between groups. IPLFCS of the left middle temporal gyrus (LMTG) was identified as a potential biomarker. The IPLFC was correlated with the traditional FC (r = 0.956, p < 0.001; r = 0.946, p < 0.001) and cortical amyloid deposition (r = −0.245, p = 0.029; r = −0.185, p = 0.048) in both cohorts. Furthermore, the IPLFCS decreased across the Alzheimer's disease (AD) continuum. Its diagnostic efficiency was superior to that of existing fMRI biomarkers. These findings suggest that IPLFCS of the LMTG could be a potential biomarker of SCD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
37. Association of plasma BDNF levels with different stages of Alzheimer's disease: a cross-sectional study.
- Author
-
Wang, Ting, Li, Taoran, Hao, Shuwen, Han, Ying, and Cai, Yanning
- Subjects
ALZHEIMER'S disease ,BRAIN-derived neurotrophic factor ,AMNESTIC mild cognitive impairment ,CROSS-sectional method - Abstract
Growing evidence shows that the expression of brain-derived neurotrophic factor (BDNF) is altered in the peripheral blood of participants with Alzheimer's disease (AD). It is unclear, however, whether altered BDNF expression is also observed in the early stages of AD. In the present study, 138 normal controls (NC), 57 participants with subjective cognitive decline (SCD), and 37 participants with amnestic mild cognitive impairment (aMCI) and AD were included. Plasma BDNF protein levels were assessed using a commercial multiplex Luminex-based kit. Patient samples were also probed for the presence of BDNF gene variant rs6265. Pairwise comparisons between the groups showed that there was not a significant difference in BDNF levels when comparing SCD with NC and when comparing SCD with aMCI/AD, but BDNF levels in aMCI/AD samples were increased when compared with NC samples. For models differentiating clinical groups, discriminant analysis was performed by including education, APOE genotype, and BDNF levels in the model. This approach distinguishes participants with SCD (AUC = 0.630) and aMCI/AD (AUC = 0.665) from NC. Our results suggest that expression of BDNF in plasma is altered at the clinical stage of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
38. Generative adversarial network constrained multiple loss autoencoder: A deep learning‐based individual atrophy detection for Alzheimer's disease and mild cognitive impairment.
- Author
-
Shi, Rong, Sheng, Can, Jin, Shichen, Zhang, Qi, Zhang, Shuoyan, Zhang, Liang, Ding, Changchang, Wang, Luyao, Wang, Lei, Han, Ying, and Jiang, Jiehui
- Subjects
GENERATIVE adversarial networks ,ALZHEIMER'S disease ,MILD cognitive impairment ,ATROPHY ,RECEIVER operating characteristic curves ,GLUCOSE-6-phosphate dehydrogenase deficiency - Abstract
Exploring individual brain atrophy patterns is of great value in precision medicine for Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, the current individual brain atrophy detection models are deficient. Here, we proposed a framework called generative adversarial network constrained multiple loss autoencoder (GANCMLAE) for precisely depicting individual atrophy patterns. The GANCMLAE model was trained using normal controls (NCs) from the Alzheimer's Disease Neuroimaging Initiative cohort, and the Xuanwu cohort was employed to validate the robustness of the model. The potential of the model for identifying different atrophy patterns of MCI subtypes was also assessed. Furthermore, the clinical application potential of the GANCMLAE model was investigated. The results showed that the model can achieve good image reconstruction performance on the structural similarity index measure (0.929 ± 0.003), peak signal‐to‐noise ratio (31.04 ± 0.09), and mean squared error (0.0014 ± 0.0001) with less latent loss in the Xuanwu cohort. The individual atrophy patterns extracted from this model are more precise in reflecting the clinical symptoms of MCI subtypes. The individual atrophy patterns exhibit a better discriminative power in identifying patients with AD and MCI from NCs than those of the t‐test model, with areas under the receiver operating characteristic curve of 0.867 (95%: 0.837–0.897) and 0.752 (95%: 0.71–0.790), respectively. Similar findings are also reported in the AD and MCI subgroups. In conclusion, the GANCMLAE model can serve as an effective tool for individualised atrophy detection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
39. Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer’s disease based on multi-modal MRI techniques
- Author
-
Hu, Zhongjie, Wu, Liyong, Jia, Jianping, and Han, Ying
- Published
- 2014
- Full Text
- View/download PDF
40. An application study-subjective cognitive decline Questionnaire9 in detecting mild cognitive impairment (MCI).
- Author
-
Hao, Lixiao, Jia, Jianguo, Xing, Yue, and Han, Ying
- Subjects
ALZHEIMER'S disease ,MILD cognitive impairment ,AGE distribution ,QUESTIONNAIRES ,LOGISTIC regression analysis ,RECEIVER operating characteristic curves ,SENSITIVITY & specificity (Statistics) ,DATA analysis software ,EARLY diagnosis ,EDUCATIONAL attainment - Abstract
Objective: Subjective cognitive decline (SCD) complaints as the early manifestation of mild cognitive impairment (MCI) may be harbingers of objective cognitive decline. SCD-questinnaire9 (SCD-Q9) is developed to investigate the early sign for MCI. However, few studies have reported its power for discriminating MCI from healthy controls (HCs). Therefore, this study aims to investigate the discrimination power of SCD-Q9 as a brief screening tool for early detection of SCD in MCI. Methods: 84 HCs and 205 people with MCI were recruited. Their demographic information and scores of SCD-Q9 were compared. A binary logistic regression model was used to analyze the potential affecting factors of MCI, and the Receiver Operating Characteristic analysis was applied to test the discrimination powers of those factors, including SCD-Q9. Results: (1) Single and total scores of SCD-Q9 were all lower in the MCI group than those in the HC group. (2) Ageing, lower education and higher total scores of SCD-Q9 were associated with MCI. (3) Area Under the Curves (AUC) of SCD-Q9 for discriminating MCI from HC group was 0.815 and when integrating age and education, the AUC improved slightly and reached 0.839. Additionally, the sensitivity and specificity were 68.8% and 85.7%, respectively when a cut-off value of 3 was applied. Conclusions: SCD-Q9 may be able to detect the subjective cognitive decline in MCI early, but it may be used together with other screening questionnaires to improve its sensitivity and further verification of its power is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
41. Global Network Analysis of Alzheimer's Disease with Minimum Spanning Trees.
- Author
-
Canario, Edgar, Chen, Donna, Han, Ying, Niu, Haijing, and Biswal, Bharat
- Subjects
BRAIN ,ALZHEIMER'S disease - Abstract
Background: A minimum spanning tree (MST) is a unique efficient network comprising the necessary connections needed to connect all regions in a network while retaining the lowest possible cost of connection weight.Objective: This study aimed to utilize functional near-infrared spectroscopy (fNIRS) to analyze brain activity in different regions and then construct MST-based regions to characterize the brain topologies of participants with Alzheimer's disease (AD), mild cognitive impairment (MCI), and normal controls (NC).Methods: A 46 channel fNIRS setup was used on all participants, with correlation being calculated for each channel pair. An MST was constructed from the resulting correlation matrix, from which graph theory measures were calculated. The average number of connections within a lobe in the left versus right hemisphere was calculated to identify which lobes displayed and abnormal amount of connectivity.Results: Compared to those in the MCI group, the AD group showed a less integrated network structure, with a higher characteristic path length, but lower leaf fraction, maximum degree, and degree divergence. The AD group also showed a higher number of connections in the frontal lobe within the left hemisphere and a lower number between hemispheric frontal lobes as compared to MCI.Conclusion: These results indicate a deviation in network structure and connectivity within patient groups that is consistent with the theory of dysconnectivity for AD. Additionally, the AD group showed strong correlations between the Hamilton depression rating scale and different graph metrics, suggesting a link between network organization and the recurrence of depression in AD. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
42. Impaired time-distance reconfiguration patterns in Alzheimer's disease: a dynamic functional connectivity study with 809 individuals from 7 sites.
- Author
-
Du, Kai, Chen, Pindong, Zhao, Kun, Qu, Yida, Kang, Xiaopeng, Liu, Yong, the Multi-center Alzheimer Disease Imaging Consortium, Zhang, Xi, Zhou, Yuying, Han, Ying, and Wang, Qing
- Subjects
ALZHEIMER'S disease ,FUNCTIONAL connectivity ,DEFAULT mode network ,BRAIN imaging - Abstract
Background: The dynamic functional connectivity (dFC) has been used successfully to investigate the dysfunction of Alzheimer's disease (AD) patients. The reconfiguration intensity of nodal dFC, which means the degree of alteration between FCs at different time scales, could provide additional information for understanding the reconfiguration of brain connectivity. Results: In this paper, we introduced a feature named time distance nodal connectivity diversity (tdNCD), and then evaluated the network reconfiguration intensity in every specific brain region in AD using a large multicenter dataset (N = 809 from 7 independent sites). Our results showed that the dysfunction involved in three subnetworks in AD, including the default mode network (DMN), the subcortical network (SCN), and the cerebellum network (CBN). The nodal tdNCD inside the DMN increased in AD compared to normal controls, and the nodal dynamic FC of the SCN and the CBN decreased in AD. Additionally, the classification analysis showed that the classification performance was better when combined tdNCD and FC to classify AD from normal control (ACC = 81%, SEN = 83.4%, SPE = 80.6%, and F1-score = 79.4%) than that only using FC (ACC = 78.2%, SEN = 76.2%, SPE = 76.5%, and F1-score = 77.5%) with a leave-one-site-out cross-validation. Besides, the performance of the three classes classification was improved from 50% (only using FC) to 53.3% (combined FC and tdNCD) (macro F1-score accuracy from 46.8 to 48.9%). More importantly, the classification model showed significant clinically predictive correlations (two classes classification: R = −0.38, P < 0.001; three classes classification: R = −0.404, P < 0.001). More importantly, several commonly used machine learning models confirmed that the tdNCD would provide additional information for classifying AD from normal controls. Conclusions: The present study demonstrated dynamic reconfiguration of nodal FC abnormities in AD. The tdNCD highlights the potential for further understanding core mechanisms of brain dysfunction in AD. Evaluating the tdNCD FC provides a promising way to understand AD processes better and investigate novel diagnostic brain imaging biomarkers for AD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
43. A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway.
- Author
-
Han, Ying, Chen, Le, Liu, Jingyun, Chen, Jie, Wang, Chunyang, Guo, Yu, Yu, Xuebin, Zhang, Chenghong, Chu, Haiying, and Ma, Haiying
- Subjects
- *
SODIUM channels , *GLUTAMATE receptors , *AMPA receptors , *HISTONE deacetylase inhibitors , *CYTOSKELETAL proteins , *DENDRITIC spines , *NEURONS , *GENE transfection - Abstract
As a neurodegenerative disease, Alzheimer's disease (AD) seriously affects the health of older people. Changes in synapses occur first over the course of the disease, perhaps even before the formation of Aβ plaques. Histone deacetylase (HDAC) mediates the damage of Aβ oligomers to dendritic spines. Therefore, we examined the relationship between HDAC activity and synaptic defects using an HDAC inhibitor (HDACI), BG45, in the human neuroblastoma SH-SY5Y cell line with stable overexpression of Swedish mutant APP (APPsw) and in APP/PS1 transgenic mice during this study. The cells were treated with 15 μM BG45 and the APP/PS1 mice were treated with 30 mg/kg BG45. We detected the levels of synapse-related proteins, HDACs, tau phosphorylation, and amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors using Western blotting and immunohistochemistry. We also measured the expression of cytoskeletal proteins in the cell model. The mRNA levels of the glutamate ion receptor alginate subunit 2 (GRIK2), sodium voltage-gated channel beta subunit (SCN3B), synaptophysin (SYP), Grm2 (the gene encoding glutamate receptor subunit 2 (GluR2)), Grid2IP, glutamate receptor interacting protein 1 (GRIP1), and GRIP2 were detected to explore the effects of the HDACI on regulating the expression of synaptic proteins and AMPA receptors. According to our studies, the expressions of HDAC1, HDAC2, and HDAC3 were increased, which were accompanied by the downregulation of the synapse-related proteins SYP, postsynaptic dendritic protein (PSD-95), and spinophilin as early as 24 h after transfection with the APPsw gene. BG45 upregulated the expression of synapse-related proteins and repaired cytoskeletal damage. In vivo, BG45 alleviated the apoptosis-mediated loss of hippocampal neurons, upregulated synapse-related proteins, reduced Aβ deposition and phosphorylation of tau, and increased the levels of the synapse-related genes GRIK2, SCN3B, SYP, Grm2, and Grid2IP. BG45 increased the expression of the AMPA receptor subunits GluA1, GluA2, and GluA3 on APPsw-transfected cells and increased GRIP1 and GRIP2 expression and AMPA receptor phosphorylation in vivo. Based on these results, HDACs are involved in the early process of synaptic defects in AD models, and BG45 may rescue synaptic damage and the loss of hippocampal neurons by specifically inhibiting HDAC1, HDAC2, and HDAC3, thereby modulating AMPA receptor transduction, increasing synapse-related gene expression, and finally enhancing the function of excitatory synapses. BG45 may be considered a potential drug for the treatment of early AD in further studies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
44. Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study.
- Author
-
Zhao, Xing, Du, Wenying, Jiang, Jiehui, and Han, Ying
- Abstract
Background: Sleep appears to be a sensitive biomarker that facilitates early detection and effective intervention for Alzheimer's disease, while subjective cognitive decline (SCD) is a risk factor for Alzheimer's disease. Prefrontal cortex atrophy is associated with both sleep disruption and cognitive decline. Transcranial brain photobiomodulation (PBM) therapy can enhance frontal cortex oxygen consumption, increasing frontal cortex mediated memory function.Objective: This study aimed to test whether PBM therapy targeting the frontal cortex could improve sleep and cognitive function in SCD.Methods: Fifty-eight SCDs were divided into the PBM group (N = 32) in which real light therapy was administered and a sham light therapy group (N = 26). All the participants received either real light or sham light therapy for 6 days consecutively, while the sleep data were recorded. The n-back task was employed to measure each participant's working memory.Results: We found no differences in sleep efficiency change (F = 211, p = 0.279), REM stage percent change (F = 420, p = 0.91), and wake-up time (F = 212, p = 0.277) between the two groups. The sleep efficiency and REM were improved within the true light group on the fifth day. The true light group perform better than the control group in the n-back test, the accuracy was higher in the 2-back test (88.6% versus 79.6%, p = 0.001), and the reaction time in 1-back was shorter (544.80±202.00 versus 592.87±222.05, p = 0.003).Conclusion: After five days of PBM therapy targeting the prefrontal cortex, sleep efficiency and N-back cognitive performance were improved on the fifth day. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
45. Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design.
- Author
-
Sheng, Can, Yang, Kun, He, Beiqi, Li, Taoran, Wang, Xiaoqi, Du, Wenying, Hu, Xiaochen, Jiang, Jiehui, Jiang, Xueyan, Jessen, Frank, and Han, Ying
- Subjects
ALZHEIMER'S disease ,NEUROPSYCHOLOGICAL tests ,ETHNOLOGY research ,PEPTIDES ,LONGITUDINAL method - Abstract
Background: Subjective cognitive decline (SCD) is considered as the first symptomatic manifestation of Alzheimer's disease (AD), which is also affected by different cultural backgrounds. Establishing cross-cultural prediction models of SCD is challenging.Objective: To establish prediction models of SCD available for both the Chinese and European populations.Methods: In this project, 330 SCD from China and 380 SCD from Germany are intended to be recruited. For all participants, standardized assessments, including clinical, neuropsychological, apolipoprotein E (APOE) genotype, blood, and multi-parameter magnetic resonance imaging (MRI) at baseline will be conducted. Participants will voluntarily undergo amyloid positron emission tomography (PET) and are classified into amyloid-β (Aβ) positive SCD (SCD+) and Aβ negative SCD (SCD-). First, baseline data of all SCD individuals between the two cohorts will be compared. Then, key features associated with brain amyloidosis will be extracted in SCD+ individuals, and the diagnosis model will be established using the radiomics method. Finally, the follow-up visits will be conducted every 12 months and the primary outcome is the conversion to mild cognitive impairment or dementia. After a 4-year follow-up, we will extract factors associated with the conversion risk of SCD using Cox regression analysis.Results: At present, 141 SCD from China and 338 SCD from Germany have been recruited. Initial analysis showed significant differences in demographic information, neuropsychological tests, and regional brain atrophy in SCD compared with controls in both cohorts.Conclusion: This project may be of great value for future implications of SCD studies in different cultural backgrounds.Trial Registration: ClinicalTrials.gov, NCT04696315. Registered 3 January 2021. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
46. Difference in Amyloid Load Between Single Memory Domain and Multidomain Subjective Cognitive Decline: A Study from the SILCODE.
- Author
-
Wang, Xiaoqi, Bi, Qiuhui, Lu, Jie, Chan, Piu, Hu, Xiaochen, Su, Li, Jessen, Frank, Lin, Hua, Han, Chunlei, Shu, Ni, Liu, Hesheng, and Han, Ying
- Subjects
COGNITION disorders ,AMYLOID ,EPISODIC memory ,MULTIPLE regression analysis ,POSITRON emission tomography ,TEMPORAL lobe ,CLINICAL neuropsychology ,PROTEIN metabolism ,BRAIN ,RESEARCH ,RESEARCH methodology ,EVALUATION research ,NEUROPSYCHOLOGICAL tests ,COMPARATIVE studies ,EMISSION-computed tomography - Abstract
Background: Subjective cognitive decline (SCD), an at-risk condition of Alzheimer's disease (AD), can involve various cognitive domains, such as memory, language, planning, and attention.Objective: We aim to explore the difference in amyloid load between the single memory domain SCD (sd-SCD) and the multidomain SCD (md-SCD) and assess the relationship of amyloid pathology with quantitative SCD scores and objective cognition.Methods: A total of 63 SCD participants from the SILCODE study underwent the clinical evaluation, neuropsychological assessment, and 18F-florbetapir PET scan. Global amyloid standard uptake value ratio (SUVr) was calculated. Additionally, regional amyloid SUVr was quantified in 12 brain regions of interests. A nonparametric rank ANCOVA was used to compare the global and regional amyloid SUVr between the md-SCD (n = 34) and sd-SCD (n = 29) groups. A multiple linear regression analysis was conducted to test the relationship of amyloid SUVr with quantitative SCD scores and objective cognition.Results: Compared with individuals with sd-SCD, individuals with md-SCD had increased global amyloid SUVr (F = 5.033, p = 0.029) and regional amyloid SUVr in the left middle temporal gyrus (F = 12.309, p = 0.001; Bonferroni corrected), after controlling for the effects of age, sex, and education. When pooling all SCD participants together, the increased global amyloid SUVr was related with higher SCD-plus sum scores and lower Auditory Verbal Learning Test-delayed recall scores.Conclusion: According to our findings, individuals with md-SCD showed higher amyloid accumulation than individuals with sd-SCD, suggesting that md-SCD may experience a more advanced stage of SCD. Additionally, increased global amyloid load was predictive of a poorer episodic memory function in SCD individuals. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
47. Coupling relationship between glucose and oxygen metabolisms to differentiate preclinical Alzheimer's disease and normal individuals.
- Author
-
Ding, Changchang, Du, Wenying, Zhang, Qi, Wang, Luyao, Han, Ying, and Jiang, Jiehui
- Subjects
ALZHEIMER'S disease ,DEFAULT mode network ,GLUCOSE metabolism ,POSITRON emission tomography ,RECEIVER operating characteristic curves - Abstract
The discovery of preclinical Alzheimer's disease (preAD) provides a wide time window for the early intervention of AD. The coupling relationships between glucose and oxygen metabolisms from hybrid PET/MRI can provide complementary information on the brain's physiological state for preAD. In this study, we purpose to explore the change of coupling relationship among 27 normal controls (NCs), 20 preADs, and 15 cognitive impairments (CIs). For each subject, we calculated the Spearman partial correlation between the fractional amplitude of low‐frequency fluctuations (fALFF) and the regional homogeneity (ReHo) from functional image (fMRI), and the standard uptake value ratio (SUVR) from [18F] fluorodeoxyglucose positron emission tomography (18F‐FDG PET), in the whole‐brain and default mode network (DMN) as a novel potential biomarker. The diagnostic performance of this biomarker was evaluated by the receiver operating characteristic analysis. Significant Spearman correlations between the FDG SUVR and the fALFF/ReHo were found in 98% of subjects. For the DMN‐based biomarker, there was a significant decreasing trend for the preAD and CI groups compared to the NC group, whereas no significant difference in preAD based on whole‐brain. The correlation ρ value for the FDG SUVR/ReHo showed the highest area under curve of the preAD classification (0.787). The results imply the coupling relationship changed during the preAD stage in the DMN area. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
48. Association of HMOX‐1 with sporadic Alzheimer's disease in southern Han Chinese.
- Author
-
Zhang, Bei, Yu, Hong‐Xiang, Zhi, Nan, Cui, Can, Han, Ying‐Ying, Hu, Min, Shen, Hao, Bao, Huan, and Li, Gang
- Subjects
ALZHEIMER'S disease ,CHINESE people ,GENDER ,ODDS ratio - Abstract
Background and purpose: The aim of this study was to discover the associations between HMOX‐1 and Alzheimer's disease (AD). Methods: A total of 500 AD patients and 500 healthy controls were recruited in this study. Polymer chain reaction was used. Results: There was a statistically significant difference between AD patients and controls in both the dominant and recessive models of HMOX‐1 rs2071746 after adjustment for age, gender and education (dominant model: p = 0.047, odds ratio [OR] 1.34, 95% confidence interval [CI] 1.00–1.78, adjusted; recessive model: p = 0.049, OR 1.34, 95% CI 1.00–1.80, adjusted). There was also a trend for an association between the dominant model and late‐onset AD after adjustment for age, gender and education (dominant model: p = 0.084, OR 1.37, 95% CI 0.96–1.95, adjusted). Conclusions: We found an association between the dominant and recessive models of HMOX1 rs2071746 and AD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
49. Divergent Connectivity Changes in Gray Matter Structural Covariance Networks in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
- Author
-
Fu, Zhenrong, Zhao, Mingyan, He, Yirong, Wang, Xuetong, Lu, Jiadong, Li, Shaoxian, Li, Xin, Kang, Guixia, Han, Ying, and Li, Shuyu
- Subjects
AMNESTIC mild cognitive impairment ,ALZHEIMER'S disease ,GRAY matter (Nerve tissue) ,MILD cognitive impairment ,COGNITIVE ability ,DEMENTIA - Abstract
Alzheimer's disease (AD) has a long preclinical stage that can last for decades prior to progressing toward amnestic mild cognitive impairment (aMCI) and/or dementia. Subjective cognitive decline (SCD) is characterized by self-experienced memory decline without any evidence of objective cognitive decline and is regarded as the later stage of preclinical AD. It has been reported that the changes in structural covariance patterns are affected by AD pathology in the patients with AD and aMCI within the specific large-scale brain networks. However, the changes in structural covariance patterns including normal control (NC), SCD, aMCI, and AD are still poorly understood. In this study, we recruited 42 NCs, 35 individuals with SCD, 43 patients with aMCI, and 41 patients with AD. Gray matter (GM) volumes were extracted from 10 readily identifiable regions of interest involved in high-order cognitive function and AD-related dysfunctional structures. The volume values were used to predict the regional densities in the whole brain by using voxel-based statistical and multiple linear regression models. Decreased structural covariance and weakened connectivity strength were observed in individuals with SCD compared with NCs. Structural covariance networks (SCNs) seeding from the default mode network (DMN), salience network, subfields of the hippocampus, and cholinergic basal forebrain showed increased structural covariance at the early stage of AD (referring to aMCI) and decreased structural covariance at the dementia stage (referring to AD). Moreover, the SCN seeding from the executive control network (ECN) showed a linearly increased extent of the structural covariance during the early and dementia stages. The results suggest that changes in structural covariance patterns as the order of NC-SCD-aMCI-AD are divergent and dynamic, and support the structural disconnection hypothesis in individuals with SCD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
50. Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
- Author
-
Sheng, Can, Lin, Li, Lin, Hua, Wang, Xiaoni, Han, Ying, and Liu, Shu-Lin
- Subjects
GUT microbiome ,POSITRON emission tomography ,COGNITION disorders ,MILD cognitive impairment ,RIBOSOMAL RNA ,ALZHEIMER'S disease - Abstract
Background: Subjective cognitive decline (SCD) is the earliest symptomatic manifestation of preclinical Alzheimer's disease (AD). Gut microbiota may serve as a susceptibility factor for AD. Altered gut microbiota has been reported in patients with mild cognitive impairment (MCI) and AD dementia. However, whether gut microbial compositions changed in SCD remains largely unknown.Objective: To characterize the gut microbiota in SCD.Methods: In this study, a total of 105 participants including 38 normal controls (NC), 53 individuals with SCD, and 14 patients with cognitive impairment (CI) were recruited. Gut microbiota of all participants isolated from fecal samples were investigated using 16S ribosomal RNA (rRNA) Illumina Miseq sequencing technique. The gut microbial compositions were compared among the three groups, and the association between altered gut microbiota and cognitive performance was analyzed. To validate the alteration of gut microbiota in SCD, we conducted amyloid positron emission tomography (PET) in selected participants and further compared the gut microbiota among subgroups.Results: The abundance of phylum Firmicutes, class Clostridia, order Clostridiales, family Ruminococcaceae, and genus Faecalibacterium showed a trend toward a progressive decline from NC to SCD and CI. Specifically, the abundance of the anti-inflammatory genus Faecalibacterium was significantly decreased in SCD compared with NC. In addition, altered bacterial taxa among the three groups were associated with cognitive performance. The findings were validated in SCD participants with positive amyloid evidence.Conclusion: The composition of gut microbiota is altered in individuals with SCD. This preliminary study will provide novel insights into the pathophysiological mechanism of AD. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.